Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Phase 1/2 trial of total marrow and lymph node irradiation to augment reduced-intensity transplantation for advanced hematologic malignancies

Joseph Rosenthal, Jeffrey Wong, Anthony Stein, Dajun Qian, Debbie Hitt, Hossameldin Naeem, Andrew Dagis, Sandra H. Thomas, Stephen Forman

Blood (2011) 117 (1): 309–315.

https://doi.org/10.1182/blood-2010-06-288357

Published: 2011

Journal Articles

Adding Total Marrow and Lymph Node Irradiation (TMLI) Using Helical Tomotherapy to Reduced Intensity Conditioning (RIC) Regimen of Fludarabine (FLU) and Melphalan (MEL) in Patients (pts) with Advanced Hematological Malignancies.

Joseph Rosenthal, Jeffrey Y. Wong, George Somlo, David Snyder, Margaret O’Donnell, Anthony Stein, Ayurporn Nademanee, Maria Delioukina, Leslie Popplewell, Pablo Parker, Ricardo Spielberger, Firoozeh Sahebi, Chatchada Karanes, Debbie Hitt, Hossameldin Naeem, Andrew Dagis, Stephen Forman

Blood (2008) 112 (11): 3271.

https://doi.org/10.1182/blood.V112.11.3271.3271

Published: 2008

Journal Articles

Iron Overload Adversely Affects Survival and Increases Risk of Graft-Versus-Host Disease and Blood Stream Infections after Allogeneic Hematopoietic Stem Cell Transplantation.

Vinod Pullarkat, MD, Suzette Blanchard, PhD, Bernard Tegtmeier, PhD, Andrew Dagis, MS, Kathryn Patane, RN, James Ito, MD, Stephen J. Forman, MD

Blood (2007) 110 (11): 2981.

https://doi.org/10.1182/blood.V110.11.2981.2981

Published: 2007

Journal Articles

Peripheral Hematopoietic Stem Cell Mobilization and Collection Efficacy Is Not an Independent Prognostic Factor for Autologous Stem Cell Transplantation.

Shirong Wang, MD, Auayporn P. Nademanee, MD, Dajun Qian, PhD, Andrew Dagis, PhD, Hyun-Soon Park, RN, Joy Fridey, MD, Eileen Patricia Smith, MD, David S. Snyder, MD, Ravi Bhatia, MD, Peter M. Falk, MD, Candace Kay, MT, Young Sun Kim, MD, Neil Martin Kogut, MD, Joycelynne Palmer, PhD, Joseph Rosenthal, MD, George Somlo, MD, Anthony Selwyn Stein, MD, Shan Yuan, MD, Stephen J. Forman, MD

Blood (2006) 108 (11): 5434.

https://doi.org/10.1182/blood.V108.11.5434.5434

Published: 2006

Journal Articles

Impact of Allogeneic Stem Cell Transplantation (ASCT) on Outcome of Biphenotypic Acute Leukemia (BAL):.

Amrita Y. Krishnan, MD, Karen L. Chang, MD, Henry C. Fung, MD, Margaret O’Donnell, MD, Ravi Bhatia, MD, Ricardo Spielberger, MD, Vinod Pullarkat, MD, Anthony Stein, MD, Neil Kogut, MD, Mark Kirschbaum, MD, Ellen Bolotin, MD, Clarence SarkodeeAdoo, MD, Andrew Dagis, MS, Nigel Cheng, Stephen J. Forman, MD

Blood (2004) 104 (11): 5144.

https://doi.org/10.1182/blood.V104.11.5144.5144

Published: 2004

Journal Articles

Results of High-Dose Therapy and Autologous Bone Marrow/Stem Cell Transplantation During Remission in Poor-Risk Intermediate- and High-Grade Lymphoma: International Index High and High-Intermediate Risk Group

Blood (1997) 90 (10): 3844–3852.

https://doi.org/10.1182/blood.V90.10.3844

Published: 1997

NARROW

Phase 1/2 trial of total marrow and lymph node irradiation to augment reduced-intensity transplantation for advanced hematologic malignancies

Adding Total Marrow and Lymph Node Irradiation (TMLI) Using Helical Tomotherapy to Reduced Intensity Conditioning (RIC) Regimen of Fludarabine (FLU) and Melphalan (MEL) in Patients (pts) with Advanced Hematological Malignancies.

Iron Overload Adversely Affects Survival and Increases Risk of Graft-Versus-Host Disease and Blood Stream Infections after Allogeneic Hematopoietic Stem Cell Transplantation.

Peripheral Hematopoietic Stem Cell Mobilization and Collection Efficacy Is Not an Independent Prognostic Factor for Autologous Stem Cell Transplantation.

Impact of Allogeneic Stem Cell Transplantation (ASCT) on Outcome of Biphenotypic Acute Leukemia (BAL):.

Results of High-Dose Therapy and Autologous Bone Marrow/Stem Cell Transplantation During Remission in Poor-Risk Intermediate- and High-Grade Lymphoma: International Index High and High-Intermediate Risk Group

Email alerts

ASH Publications

American Society of Hematology

Phase 1/2 trial of total marrow and lymph node irradiation to augment reduced-intensity transplantation for advanced hematologic malignancies

Adding Total Marrow and Lymph Node Irradiation (TMLI) Using Helical Tomotherapy to Reduced Intensity Conditioning (RIC) Regimen of Fludarabine (FLU) and Melphalan (MEL) in Patients (pts) with Advanced Hematological Malignancies.

Iron Overload Adversely Affects Survival and Increases Risk of Graft-Versus-Host Disease and Blood Stream Infections after Allogeneic Hematopoietic Stem Cell Transplantation.

Peripheral Hematopoietic Stem Cell Mobilization and Collection Efficacy Is Not an Independent Prognostic Factor for Autologous Stem Cell Transplantation.

Impact of Allogeneic Stem Cell Transplantation (ASCT) on Outcome of Biphenotypic Acute Leukemia (BAL):.

Results of High-Dose Therapy and Autologous Bone Marrow/Stem Cell Transplantation During Remission in Poor-Risk Intermediate- and High-Grade Lymphoma: International Index High and High-Intermediate Risk Group

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only